Cybin Inc. (HELP) Stock Forecast

NASDAQ: HELPAnalyst ratings, price target and estimates.

HELP analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.91 / 5 from 11 analysts
Price target
$40.44
average of analyst targets
Upside to target
+283.3%
from the latest close
Next earnings
November 12, 2026
EPS estimate $-0.67
52-week range
$3.87 – $14.02

HELP analyst ratings

11 analysts
Strong buy
1091%
Buy
19%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

HELP price target

Price $10.55Target $40.44
52-week low $3.8752-week high $14.02

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

HELP earnings per share estimates

Cybin Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.95−$1.17−$0.57−$1.65+42.7%5
Next quarter (Dec '26)−$0.88−$1.07−$0.64−$1.36+35.4%5
Current fiscal year (FY2027)−$3.72−$4.43−$2.86−$5.91+37.1%4
Next fiscal year (FY2028)−$2.54−$3.04−$2.04−$3.72+31.7%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

HELP revenue estimates

Cybin Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$0$0$00.0%8
Next quarter (Dec '26)$0$0$00.0%8
Current fiscal year (FY2027)$0$0$00.0%7
Next fiscal year (FY2028)$11.1M$0$48.2M0.0%6

HELP EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

HELP revenue: reported and forecast

Reported revenueEstimate (average; low–high)

HELP EPS estimate revisions

Cybin Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$1.09−$1.07−$0.94−$0.94−$0.95−13.3%0 up · 1 down
Next quarter (Dec '26)−$1.11−$1.01−$0.88−$0.88−$0.88−20.5%0 up · 1 down
Current fiscal year (FY2027)−$4.43−$4.35−$3.71−$3.71−$3.72−16.1%0 up · 1 down
Next fiscal year (FY2028)−$3.97−$3.97−$3.30−$2.76−$2.54−36.0%1 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

HELP earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; HELP beat in 4 of 11.

What analysts expect from HELP

11 analysts cover Cybin; their consensus rating is strong buy (4.91 on a 1–5 scale, where 5 is a strong buy). The average price target is $40.44, 283.3% above the latest close of $10.55. Analysts expect earnings of −$3.72 per share for FY2027, +37.1% from a year earlier. For FY2028 the average estimate is −$2.54 per share on revenue of $11.1 million. Cybin beat the EPS estimate in 4 of the last 11 quarters.

Related: HELP income statement, HELP key metrics, HELP chart. See the HELP stock overview for the latest quote and news.

HELP forecast FAQ

What is Cybin's price target?

The average analyst price target for Cybin is $40.44, 283.3% above the latest close of $10.55.

Is Cybin a buy, hold or sell?

Of 11 analysts covering Cybin, 10 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Cybin's EPS forecast?

Analysts forecast −$3.72 per share for FY2027 (range −$4.43 to −$2.86); for FY2028 the estimate is −$2.54.

When does Cybin report earnings?

Cybin is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 before the market opens; the EPS estimate is $-0.67.

Does Cybin usually beat earnings estimates?

Cybin reported EPS at or above the analyst estimate in 4 of the last 11 quarters.

Biotechnology: forecast